Trials / Completed
CompletedNCT03109457
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma
Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma. (Retrospective-cohort Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Compare Hepatiis C Virus (HCV) detection between oral squamous cell carcinoma (OSCC) and normal tissues, to determine the possible relationship between HCV and OSCC.
Detailed description
Patient / Population: Paraffin embedded tissue samples of OSCC. Indicator: OSCC patients Control: Normal patients Formalin fixed paraffin embedded specimens from blocks retrieved from the archives of the Oral and Maxillofacial Pathology Department, Faculty of dentistry, Kasr Alini hospital setting from January 2014 till February 2018. All clinical and histopathological data from medical reports, will be reviewed and data will be collected regarding age, sex, tumor location, history of smoking and alcohol consumption, nodal status, tumor recurrences and histological classification of the patients. The specimens will be obtained from 2 groups:- 1. OSCC specimens. Histological diagnosis of H\&E stained sections will be performed according to World health organisation (WHO) guidelines by 2 independent pathologists. 2. Normal oral mucosa specimens (control). outcome: I) Immunohistochemical detection of Hepatitis C core antigen (Hep C cAg) : sc-58144, santa cruz biotechnology, USA) a mouse monoclonal antibody raised against Hepatitis C virus will be purchased and used for immunohistochemical staining. Staining procedure using an automated system Ventana Benchmark. The four µm thick paraffin embedded tissue sections will be deparaffinized in three changes of xylene then microwaved for antigen retrieval. The slides will be incubated with primary antibody overnight in the humidity chamber at room temperature. Then, the slides will be incubated with secondary antibody. The peroxidase activity will be made visible with diaminobenzidine. Finally, counterstaining will be obtained using Mayer's hematoxylin. The immunostained sections will be examined using analyzer computer system (Germany).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | oral squamous cell carcinoma | Histological diagnosis of H\&E stained sections will be performed according to WHO guidelines by 2 independent pathologists. |
Timeline
- Start date
- 2017-09-06
- Primary completion
- 2018-02-07
- Completion
- 2018-09-15
- First posted
- 2017-04-12
- Last updated
- 2020-02-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03109457. Inclusion in this directory is not an endorsement.